Ifp Advisors, Inc Caladrius Biosciences, Inc. Transaction History

Ifp Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$0.48 - $7.8 $19 - $319	41 Added 51.25%	121 $2,000
Q2 2022 Sep 06, 2022	BUY	$0.41 - $0.74 $32 - $59	80 New	80 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.41 - $0.74 $32 - $59	-80 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$2.22 - $2.99 $106 - $143	48 Added 150.0%	80 $0
Q4 2018 Jan 23, 2019	SELL	$3.49 - $5.77 $1,888 - $3,121	-541 Reduced 94.42%	32 $0

Q4 2016 Jun 03, 2019	SELL	N/A	-149 Reduced 20.64%	573 $2,000
Q2 2016 Jun 03, 2019	BUY	N/A	690 Added 2156.25%	722 $0
Q1 2016 Jun 03, 2019	BUY	N/A	32	32 $0

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.